PCI is a respected industry leader and trusted partner providing a comprehensive range of outsourced pharmaceutical services from early stage development to long term commercial supply
We have launched our new Webflow App and it's available now
Webflow is a market leading technology providing a comprehensive customer support portal which brings many benefits to our clients including access to a wide range of reports updated in real time and available 24/7, enabling more efficient and effective supply management.
PCI Pharma Services Announces Acquisition of Millmount Healthcare and Additional EU Footprint
Comprising 3 GMP approved facilities, Millmount Healthcare is able to offer a full turnkey solution including the sourcing and purchase of components, packaging and tooling design, late stage customization, analytical support services and warehousing.
Core services include: Analytical services, formulation development, clinical trial services, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution. Customers may choose to use us as a complete development partner and benefit from our full range of services or choose any of our core services as a stand-alone offering.
Q&A with Justin Schroeder, Executive Director, Marketing, Business Development and Design, PCI Pharma Services
The need for clinical trials to meet the requirements of regulators, deliver high-quality data, and come in on budget has led to study designs...
We are pleased to announce the release of a published white paper detailing Domino's study which analyzes potential leachability of ink from coding technologies used in pharmaceutical Serialization activities.
PCI Pharma Services is pleased to announce investment in a considerable expansion of our onsite Cold Chain storage at our Philadelphia site.
PCI Clinical Services has announced the launch of our expedited Clinical packaging, labeling and distribution service PCIFastTrack™. The system delivers Clinical Trial supplies for time critical studies in the shortest possible turnaround.
First Molecule to Complete the Development-to-Launch Cycle within PCI's Contained Manufacturing Facility. PCI Pharma Services has announced its first client product to move from clinical development to US commercial launch.